Outcomes from the CASSIOPEIA Trial

Amrita Krishnan, MD, Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research, Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope provides outcomes from the CASSIOPEIA trial that involves daratumumab + VTD in multiple myeloma.